Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GeneCast Biotechnology

GeneCast Biotechnology
2014 FOUNDED
PRIVATE STATUS
Series D LATEST DEAL TYPE
$42.2M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of a cancer diagnosis and therapeutics solutions platform intended to detect tumors and cancer-causing genes in blood. The company's provides non-invasive and precise diagnosis of tumors as well as personalized cancer treatment based on high throughput sequencing, bioinformatics and cutting-edge translational medicine enabling guidance in personalized medicine to prolong patient's life span and improve their quality of life. The company is specialized in diagnosing lung cancer, colon cancer, liver cancer and breast cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 903-908, Jiankang Zhigu Industrial Park
  • No. 35, Huayuan North Road, Haidian District
  • Beijing
  • China

+86 400 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GeneCast Biotechnology’s full profile, request a free trial.

GeneCast Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 30-Oct-2019 $42.2M 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 01-Jan-2018 000.00 000.00 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 01-Jan-2017 000.00 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 01-Jan-2016 $4.04M $4.44M Completed Startup
1. Seed Round 01-Feb-2015 $402K $402K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

GeneCast Biotechnology Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RareCyte Venture Capital-Backed Seattle, WA 0000 00000000000 0000
000000000 00000 Venture Capital-Backed Siena, Italy 0000000000 0
0000000 00000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
0000000 0000000 Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

GeneCast Biotechnology Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
China Capital Investment Group PE/Buyout Minority 000 0000 000000 0
Loyal Valley Capital Growth/Expansion Minority 000 0000 000000 0
Matrix Partners China Venture Capital Minority 000 0000 000000 0
Loyal Valley Capital Advantage Fund Other Minority 000 0000 000000 0
THG Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

GeneCast Biotechnology Executive Team (5)

Name Title Board
Seat
Contact
Info
Bo Du Ph.D Co-Founder & Chief Executive Officer
Haibo Wang Chief Technology Officer
Henghui Zhang MD Co-Founder & Chief Scientific & Medical Officer
Xiao Li Director of Finance
Guosheng Ma Vice President & Co-Founder